StockData
Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc (KPRX) stock

KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.93−0.05 (-5.30%)

Close on Nov 17, 2026Market cap $4.11MP/E –Yield –

Kiora Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Kiora Pharmaceuticals's cash was $16.84M at Jun 30, 2026. For fiscal 2025 it was $17.09M, down 36.2% from the year before. Over ten years it grew 7.3% a year on average. The highest annual figure on record is $26.80M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$17.09M-36.2%
FY2024Dec 31, 2024$26.80M+989.7%
FY2023Dec 31, 2023$2.46M-59.1%
FY2022Dec 31, 2022$6.01M-23.9%
FY2021Dec 31, 2021$7.90M+541.9%
FY2020Dec 31, 2020$1.23M-67.8%
FY2019Dec 31, 2019$3.82M-52.5%
FY2018Dec 31, 2018$8.05M+2.5%
FY2017Dec 31, 2017$7.85M+113.3%
FY2016Dec 31, 2016$3.68M-56.3%
FY2015Dec 31, 2015$8.41M+4938.4%
FY2014Dec 31, 2014$167.00K-66.7%
FY2013Dec 31, 2013$501.17K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$16.84M-18.5%
Q1 FY2026Mar 31, 2026$13.87M-42.5%
Q4 FY2025Dec 31, 2025$17.09M-36.2%
Q3 FY2025Sep 30, 2025$19.38M-33.3%
Q2 FY2025Jun 30, 2025$20.67M-25.7%
Q1 FY2025Mar 31, 2025$24.11M-22.9%
Q4 FY2024Dec 31, 2024$26.80M+989.7%
Q3 FY2024Sep 30, 2024$29.04M+437.3%
Q2 FY2024Jun 30, 2024$27.82M+249.7%
Q1 FY2024Mar 31, 2024$31.28M+811.9%
Q4 FY2023Dec 31, 2023$2.46M-59.1%
Q3 FY2023Sep 30, 2023$5.40M+11.4%
Q2 FY2023Jun 30, 2023$7.96M+221.2%
Q1 FY2023Mar 31, 2023$3.43M-32.9%
Q4 FY2022Dec 31, 2022$6.01M-23.9%
Q3 FY2022Sep 30, 2022$4.85M-56.5%
Q2 FY2022Jun 30, 2022$2.48M-33.2%
Q1 FY2022Mar 31, 2022$5.11M-23.2%
Q4 FY2021Dec 31, 2021$7.90M+541.9%
Q3 FY2021Sep 30, 2021$11.15M+274.7%
Q2 FY2021Jun 30, 2021$3.71M-21.7%
Q1 FY2021Mar 31, 2021$6.66M+12.4%
Q4 FY2020Dec 31, 2020$1.23M-67.8%
Q3 FY2020Sep 30, 2020$2.98M+19.1%
Q2 FY2020Jun 30, 2020$4.73M+5.0%
Q1 FY2020Mar 31, 2020$5.92M+0.4%
Q4 FY2019Dec 31, 2019$3.82M-52.5%
Q3 FY2019Sep 30, 2019$2.50M-74.9%
Q2 FY2019Jun 30, 2019$4.51M-64.3%
Q1 FY2019Mar 31, 2019$5.90M+59.8%
Q4 FY2018Dec 31, 2018$8.05M+2.5%
Q3 FY2018Sep 30, 2018$9.95M+7.6%
Q2 FY2018Jun 30, 2018$12.65M+7.1%
Q1 FY2018Mar 31, 2018$3.69M-32.6%
Q4 FY2017Dec 31, 2017$7.85M+113.3%
Q3 FY2017Sep 30, 2017$9.24M+62.7%
Q2 FY2017Jun 30, 2017$11.81M–
Q1 FY2017Mar 31, 2017$5.48M–
Q4 FY2016Dec 31, 2016$3.68M–
Q3 FY2016Sep 30, 2016$5.68M–

More Kiora Pharmaceuticals figures

See a number that looks wrong?